EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Anti‐Inflammatory Therapies in Coronary Artery Disease; A Systematic Review

Louis de Courcy, Jack Moore

Clinical Cardiology · 2026-11 · 49 (11)

DOI: 10.1002/clc.70519 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Cardiology, online erschienen am 17.11.2026. Verfasst von Louis de Courcy und 1 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Pro‐inflammatory cytokines play an important role in multiple facets of coronary artery disease (CAD), from endothelial dysfunction to plaque development and rupture to reperfusion injury post‐revascularisation. We aimed to identify and present key data from randomized controlled trials (RCTs) which investigate anti‐inflammatory drugs with the goal of improving outcomes associated with CAD. Methods and Results We searched for placebo‐controlled RCTs across three databases (Cochrane Library, PubMed, and ClinicalTrials.gov ) using the terms “anti‐inflammatory” and “coronary artery disease” as well as variants. Thirty‐three studies were identified and categorized as: (a) secondary prevention of major adverse cardiovascular events (MACE), (b) secondary prevention of radiographic evidence of CAD, and (c) reduction in reperfusion injury when administered during reperfusion. Seven trials demonstrated a reduction in CAD, including five phase III trials for secondary prevention of MACE.

Conclusion

The majority of anti‐inflammatory therapies did not show improved outcomes across a variety of endpoints. However colchicine and canakinumab have shown benefit in reducing MACE in phase III trials, while tocilizumab improved myocardial salvage index when administered peri‐reperfusion. These findings suggest that the NLRP3–IL1β–IL6–CRP pathway may represent a promising therapeutic target and an important focus for future research in CAD prevention, particularly in patients with high residual inflammatory risk.

Zitieren

APA

Courcy, L. D., & Moore, J. (2026). Anti‐Inflammatory Therapies in Coronary Artery Disease; A Systematic Review. Clinical Cardiology, 49(11). https://doi.org/10.1002/clc.70519

Vancouver

Courcy LD, Moore J. Anti‐Inflammatory Therapies in Coronary Artery Disease; A Systematic Review. Clinical Cardiology. 2026;49(11). doi:10.1002/clc.70519

BibTeX
@article{Courcy2026,
  author = {Courcy, Louis de and Moore, Jack},
  title = {Anti‐Inflammatory Therapies in Coronary Artery Disease; A Systematic Review},
  journal = {Clinical Cardiology},
  year = {2026},
  volume = {49},
  number = {11},
  doi = {10.1002/clc.70519}
}
Kostenlos starten →